Defective Breast Mesh, Acellular Dermal Matrix, and Bioabsorbable Scaffold Injury Attorneys in Massachusetts: The Complete Guide for Women, Families, and Survivors

For women across Massachusetts—from the specialized surgical suites of the Longwood Medical Area in Boston to the community health centers of Worcester and the reconstruction clinics in Springfield—the promise of modern breast surgery is often intertwined with hope. Whether you are a breast cancer survivor navigating the complex stages of reconstruction, a woman carrying a BRCA1 or BRCA2 mutation who chose a prophylactic mastectomy to save your life, or a cosmetic patient seeking a revision or augmentation, you were likely told that the materials used in your body were the gold standard of safety.

The reality we see today in Massachusetts healthcare is far more troubling. Thousands of women are realizing that the surgical mesh, acellular dermal matrix (ADM), and bioabsorbable scaffolds implanted during their procedures were never formally proved safe for use in breast tissue by the FDA. Instead, these devices entered the market through a regulatory shortcut known as the 510(k) clearance pathway—a process that values “substantial equivalence” to older devices over actual clinical testing for specific surgeries.

At The Manginello Law Firm, PLLC, operating under the brand Attorney911, we have watched this regulatory failure unfold with devastating consequences for patients. Managing Partner Ralph Manginello, with twenty-seven years of continuous legal practice under Texas Bar Card Number 24007597, leads our efforts to hold medical device manufacturers accountable for the physical, emotional, and financial toll these defective products take on women. Along with Associate Attorney Lupe Peña, who conducts full client consultations in fluent Spanish, our firm provides the technical command and compassionate authority needed to prosecute complex product liability cases.

If you have experienced chronic pain, severe infection, reconstruction failure, or have been diagnosed with rare cancers like BIA-ALCL or BIA-SCC after your surgery in Massachusetts, we are here to provide answers. You are not alone in this fight, and the law provides a pathway for those whose bodies were treated as testing grounds for unproven materials.

When you are ready to speak with an experienced advocate who understands the medical and legal complexities of your situation, call us at 1-888-ATTY-911 (1-888-288-9911) for a confidential consultation. There is no cost, no obligation, and we work on a contingency-fee basis—meaning we do not get paid unless we recover compensation for you.

Understanding the Devices: Mesh, ADM, and Bioabsorbable Scaffolds

To handle the complications arising from your surgery, we must first look at the materials themselves. In Massachusetts, surgeons frequently use three categories of reinforcing materials to provide support for breast implants or tissue expanders, often referred to in marketing as the “internal bra” technique.

Acellular Dermal Matrix (ADM)

ADM is a biologic material derived from human or animal skin tissue. Through a process of decellularization, the cells are stripped away, leaving a collagen scaffold that is intended to integrate with your own tissue. Common brands used in Massachusetts reconstruction centers include:

• AlloDerm and AlloDerm RTU (Allergan/AbbVie)
• Strattice (porcine-derived, Allergan/AbbVie)
• FlexHD (human-derived, MTF Biologics)
• AlloMax (human-derived, C.R. Bard/Becton Dickinson)
• SurgiMend (bovine-derived, Integra LifeSciences)

Bioabsorbable and Resorbable Scaffolds

These are synthetic materials designed to provide temporary support before being absorbed by your body. The most controversial of these products—GalaFLEX and Phasix—are made from poly-4-hydroxybutyrate (P4HB). While manufacturers like Becton Dickinson claim these products resorb within 18 to 24 months, we have seen cases where the material fails to resorb properly, causing chronic inflammation or palpable mesh edges years later.

Synthetic Surgical Mesh

Occasionally, polypropylene or composite meshes, originally designed for hernia repair, have been used off-label in Massachusetts breast surgeries. These were never intended for breast tissue and can lead to severe erosions and chronic pain.

The most critical fact to understand is that no surgical mesh product has been cleared or approved by the FDA for use in breast surgery. This startling admission was made by the FDA in a November 9, 2023, letter to health care providers. When a device is used “off-label,” it means the manufacturer hasn’t proven to the FDA that it is safe for that specific purpose.

Why Massachusetts Medical Hubs Face Rising Complication Rates

Massachusetts is a global epicenter for medical innovation and high-volume surgical care. With NCI-designated comprehensive cancer centers like the Dana-Farber Brigham Cancer Center and prestigious academic institutions across the Boston metropolitan area, our state performs a staggering number of breast reconstructions and aesthetic procedures annually.

However, high volume often correlates with higher exposure to defective devices. In Massachusetts, surgeons have historically relied on ADM and scaffolds to facilitate “pre-pectoral” reconstruction—placing the implant over the muscle rather than under it. While this technique reduces muscle trauma, it places a heavy burden on the mesh or matrix to support the weight of the implant. When that material is defective, the entire reconstruction is at risk.

Our firm’s experience in handling high-profile, multi-defendant institutional liability litigation—such as the recent $10,000,000 lawsuit Bermudez v. Pi Kappa Phi Fraternity, Inc.—proves our ability to manage cases involving complex corporate structures and multiple negligent parties. We treat the manufacturers of these defective devices with the same aggressive rigor, ensuring that the healthcare systems in Massachusetts that selected these products are also evaluated for their role in your injury.

The Spectrum of Complications: From Infection to Rare Cancers

The injuries associated with defective mesh and ADM are not just “unfortunate side effects.” They are often the result of biological and mechanical failures inherent in the products themselves.

Surgical and Infectious Complications

Studies have shown that ADM-assisted reconstruction more than doubles the risk of infection compared to reconstructions performed without these materials.

• Surgical Site Infection (SSI): Can progress to sepsis, as we have seen in catastrophic cases involving intensive care unit admissions.
• Skin-Flap Necrosis: The death of breast tissue overlying the device, which can lead to total reconstruction loss.
• Red Breast Syndrome: A sterile, noninfectious inflammation specific to ADM, often caused by bacterial endotoxins—remnants of bacteria that survive the sterilization process.

The Oncological Risk: BIA-ALCL and BIA-SCC

One of the most terrifying complications is Breast Implant-Associated Anaplastic Large Cell Lymphoma (BIA-ALCL). This is a CD30-positive, ALK-negative T-cell lymphoma that has been linked primarily to textured implant surfaces. The Allergan BIOCELL textured implants, recalled worldwide in July 2019, are at the center of ongoing multidistrict litigation (MDL 2921).

Additionally, Breast Implant-Associated Squamous Cell Carcinoma (BIA-SCC) is an emerging epithelial tumor found in the implant capsule. The FDA issued safety communications in 2022 and 2023 regarding this rare but deadly cancer, which can present decades after surgery.

Mechanical and Structural Failures

For products like GalaFLEX and Phasix, the resorption process is the primary failure point.

• Premature Degradation: The scaffold loses strength before your body can support the implant, leading to “bottoming out” or asymmetry.
• Failure to Resorb: Palpable mesh edges and chronic foreign-body reactions occur when the P4HB material remains in the body longer than the advertised timeline.

If you are suffering from these complications, the first step is obtaining the truth. Lupe Peña and our bilingual team can help you navigate the process of requesting your operative reports and device implant stickers—the “lot numbers” that prove exactly which brand was used in your Massachusetts surgery. Call us at 1-888-ATTY-911 to begin this investigation.

The Regulatory Root Cause: Predicate Creep and the 510(k) Pathway

How did so many unproven products reach Massachusetts operating rooms? The answer lies in the FDA’s 510(k) clearance pathway. Unlike the Premarket Approval (PMA) process, which requires rigorous human clinical trials, the 510(k) pathway only requires a manufacturer to show that their device is “substantially equivalent” to a “predicate device.”

This has led to a phenomenon known as “predicate creep.” For example, the manufacturer of GalaFLEX cited a surgical suture as one of its predicate devices to gain clearance. A suture used for wound closure is not biologically or mechanically equivalent to a mesh scaffold used to support a breast implant, yet the FDA permitted the connection.

Ralph Manginello and our legal team are deeply versed in federal preemption doctrines, including the landmark cases Medtronic v. Lohr and Riegel v. Medtronic. Because most of these mesh and ADM products were cleared through 510(k) rather than PMA, manufacturers generally cannot use “federal preemption” to block your state-law lawsuit in Massachusetts. This is a critical legal distinction that generalist personal injury firms often miss.

Litigation Precedents and What They Mean for You

When we evaluate a case in Massachusetts, we look at the history of mesh litigation. For years, manufacturers of pelvic and transvaginal mesh paid out over $8 billion to resolve more than 100,000 claims. More recently, in October 2024, Becton Dickinson (the parent company of Bard, Davol, and Galatea Surgical) agreed to an estimated $1 billion settlement to resolve approximately 40,000 hernia mesh lawsuits.

These settlements were driven by evidence that manufacturers knew about the risks of their mesh products and failed to warn doctors and patients. We are applying these same lessons to the breast mesh and ADM cases being filed now.

While every case is different, and past results do not guarantee future outcomes, women who have suffered permanent disfigurement, reconstruction loss, or cancer after a Massachusetts surgery may be eligible for significant compensation. This includes:

• Economic Damages: Past and future medical bills, lost wages, and the cost of revision surgeries.
• Non-Economic Damages: Pain and suffering, emotional distress, and permanent scarring or loss of breast sensation.
• Punitive Damages: In cases where it can be shown the manufacturer hidden safety data.

Our firm is committed to the highest standards of ethics and service. Ralph Manginello is a member of the Pro Bono College of the State Bar of Texas, a recognition for those who exceed aspirational goals for service—a testament to the integrity and dedication we bring to every client, whether in Houston or right here in Massachusetts.

The Whistleblower: Dr. Hooman Noorchashm

The case against Becton Dickinson (BD) regarding GalaFLEX is bolstered by the bravery of whistleblowers. Dr. Hooman Noorchashm, a cardiothoracic surgeon and former BD Medical Director, was terminated in 2022 after raising concerns about the off-label marketing of GalaFLEX for breast surgery.

Dr. Noorchashm alleges that BD withheld data regarding breast cancer recurrences in its internal trials and failed to report adverse events accurately through the FDA’s Manufacturer and User Facility Device Experience (MAUDE) database. His advocacy has been pivotal in exposing how manufacturers incentivized Massachusetts surgeons to use these products without proper clinical backing.

Navigating the Legal Landscape in Massachusetts

For residents of Massachusetts, timing is a critical factor. The law in our state regarding product liability and medical injury is specific:

1. Statute of Limitations: In Massachusetts, you generally have three years from the date of injury or the date you discovered the injury was linked to the device to file a lawsuit.
2. Statute of Repose: We must also navigate Massachusetts’s three-year statute of repose, which can be even more restrictive depending on the date the product was delivered.
3. No Guarantee of Outcome: We fight aggressively for every client, but we must emphasize that every case is unique and depends on the specific facts of your surgery and the brand of device implanted.

The District of Massachusetts federal court, particularly the Boston Division, is the likely venue for many of these cases. Ralph Manginello and our firm are admitted to federal court and handle complex device litigation on a national scale. We understand the docket profiles and the realistic case paths through these courts.

Hablamos español. Lupe Peña and our bilingual team are ready to ensure that language is never a barrier to justice. In Massachusetts, where diverse communities enrich our cities, we provide the resources you need in the language you speak at home.

Frequently Asked Questions

Is surgical mesh actually approved for breast surgery?
No. The FDA explicitly stated in 2023 that no surgical mesh product has been determined to be safe or effective for use in breast reconstruction, augmentation, or internal bra procedures.

What if I had my surgery several years ago?
You may still have a case. The “discovery rule” in Massachusetts often pauses the clock on the statute of limitations until the moment you were first warned or had reason to know that your complications were linked to a defective device.

Do I need a new surgeon to file a lawsuit?
Not necessarily, although we often recommend seeking an independent second opinion at a major center like the Massachusetts General Hospital or UMass Memorial to ensure your health is prioritized.

Who do we sue—my surgeon or the manufacturer?
In most cases, the primary defendant is the manufacturer of the device for “failure to warn.” However, if a hospital or surgeon was aware of the safety communications and failed to inform you during the consent process, their actions will also be evaluated.

What is BIA-ALCL?
It is a rare but serious cancer of the immune system found in the scar tissue around breast implants. It is most commonly associated with textured surfaces, particularly the recalled Allergan BIOCELL products.

What You Should Do Right Now

If you are a woman in Massachusetts currently facing complications or concerns about your breast surgery:

1. Request Your Operative Reports: Demand a full copy of the surgical report from the hospital or surgery center where the procedure took place.
2. Identify the Product: Look for the “Implant Sticker” or “Lot Serial Number” in your records. This is the only way to know the specific brand of mesh or ADM used.
3. Document Symptoms: Keep a record of redness, swelling, pain, or fluid drainage, along with the dates they appeared.
4. Contact Counsel: Do not wait for the manufacturer to contact you. Use the independent 1-888-ATTY-911 line to speak with our firm.

Our reputation is built on independently verified ratings, including an Avvo “Excellent” tier 8.2 rating and five-star reviews from hundreds of previous clients across the country. We maintain an A+ profile with the Better Business Bureau and are recognized members of the Pasadena Chamber of Commerce and other professional bodies.

We invite you to join the conversation. Listen to our Attorney 911 podcast on Apple Podcasts or Spotify, or watch our legal updates on YouTube (@Manginellolawfirm) and Instagram (@attorney911). We believe that an informed patient is a powerful plaintiff.

Contact The Manginello Law Firm, PLLC Today

Your health and your reconstruction were meant to be a source of strength, not a source of suffering. If a medical device manufacturer prioritized their profits over your safety in a Massachusetts operating room, we are ready to hold them accountable.

Call 1-888-ATTY-911 (1-888-288-9911) today for your free, no-obligation consultation. Hablamos español. Let us help you take back control of your story and fight for the compensation you deserve. From the North Shore to the Berkshires, we stand with the women of Massachusetts.

The Manginello Law Firm, PLLC (Attorney911) provides and maintains this content for educational purposes. Past results do not guarantee future outcomes. This information does not constitute medical advice or an attorney-client relationship until a formal agreement is signed. Ralph P. Manginello is the attorney responsible for this content.